Clinical Trials Directory

Trials / Unknown

UnknownNCT02902094

Drug Eluting Balloon Venoplasty in AV Fistula Stenosis

Improving Outcomes in Fistula Intervention: A Prospective, Patient Blinded, Phase 3, Randomised Controlled Trial of Drug Eluting Balloons in the Angioplasty of Native Haemodialysis Access Arteriovenous Fistula Outflow Stenosis (DeVA)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
186 (estimated)
Sponsor
University Hospital Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

DeVA is a single blinded, prospective, multicentre RCT designed to determine the safety and effectiveness of a drug eluting angioplasty balloon compared with a standard angioplasty balloon in patients with symptomatic native AV fistula stenosis.

Conditions

Interventions

TypeNameDescription
DEVICEDrug eluting balloons
DEVICENon drug eluting balloons

Timeline

Start date
2016-01-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2016-09-15
Last updated
2016-09-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02902094. Inclusion in this directory is not an endorsement.

Drug Eluting Balloon Venoplasty in AV Fistula Stenosis (NCT02902094) · Clinical Trials Directory